Back
Parker Hannifin 10K Form
Buy
60
PH
Parker Hannifin
Last Price:
$645.75
Seasonality Move:
6.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | PH/Parker Hannifin Quarterly |
2024-02-06 | 10Q | PH/Parker Hannifin Quarterly |
2023-11-07 | 10Q | PH/Parker Hannifin Quarterly |
2023-08-24 | 10K | PH/Parker Hannifin Annual |
2023-05-05 | 10Q | PH/Parker Hannifin Quarterly |
2023-02-07 | 10Q | PH/Parker Hannifin Quarterly |
Receive PH News And Ratings
See the #1 stock for the next 7 days that we like better than PH
PH Financial Statistics
Sales & Book Value
Annual Sales: | $19.9B |
---|---|
Cash Flow: | $648.7M |
Price / Cash Flow: | 27.42 |
Annual Sales: | $100.15 |
Price / Book: | 6.46 |
Profitability
EPS (TTM): | 22.14000 |
---|---|
Net Income (TTM): | $2.9B |
Gross Margin: | $7.1B |
Return on Equity: | 24.73% |
Return on Assets: | 9.79% |
Parker Hannifin Earnings Forecast
Key Parker Hannifin Financial Ratios
-
The Gross Profit Margin over the past 41 years for PH is 35.76%.
-
The Selling, General & Administrative Expenses for PH have been equal to 16.27% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 17.81% of Operating Income.
-
The Net Earning history of PH is 14.27% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 25 years.
Parker Hannifin Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | PH |
CUSIP: | 701094 |
Website: | parker.com |
Debt
Debt-to-Equity Ratio: | 0.79 |
---|---|
Current Ratio: | 0.96 |
Quick Ratio: | 0.46 |
Price-to-Earnings
Trailing P/E Ratio: | 29.63 |
---|---|
Forward P/E Ratio: | 21.94 |
PH Technical Analysis vs Fundamental Analysis
Buy
60
Parker Hannifin (PH)
is a Buy
Is Parker Hannifin a Buy or a Sell?
-
Parker Hannifin stock is rated a BuyThe current Parker Hannifin [PH] share price is $647.20. The Score for PH is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.